Year |
Citation |
Score |
2022 |
Wong HY, Zhong H, Zhong M, Zhou X, Chan PYC, Kwok TCY, Mok K, Hardy J, Ip FCF, Fu AKY, Ip NY. Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong. Journal of Alzheimer's Disease : Jad. PMID 35466936 DOI: 10.3233/JAD-215312 |
0.337 |
|
2022 |
Cao H, Zhou X, Chen Y, Ip FCF, Chen Y, Lai NCH, Lo RMN, Tong EPS, Mok VCT, Kwok TCY, Fu AKY, Ip NY. Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer's Disease Risk. Journal of Alzheimer's Disease : Jad. PMID 35253752 DOI: 10.3233/JAD-215311 |
0.333 |
|
2021 |
Lau JKY, Tian M, Shen Y, Lau SF, Fu WY, Fu AKY, Ip NY. Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model. Scientific Reports. 11: 4359. PMID 33623128 DOI: 10.1038/s41598-021-83932-4 |
0.302 |
|
2018 |
Chen Y, Fu AKY, Ip NY. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies. Pharmacology & Therapeutics. PMID 30439458 DOI: 10.1016/J.Pharmthera.2018.11.006 |
0.332 |
|
2018 |
Zhou X, Chen Y, Mok KY, Zhao Q, Chen K, Chen Y, Hardy J, Li Y, Fu AKY, Guo Q, Ip NY. Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. PMID 29432188 DOI: 10.1073/Pnas.1715554115 |
0.304 |
|
2014 |
Fu AK, Hung KW, Huang H, Gu S, Shen Y, Cheng EY, Ip FC, Huang X, Fu WY, Ip NY. Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 111: 9959-64. PMID 24958880 DOI: 10.1073/Pnas.1405803111 |
0.304 |
|
Show low-probability matches. |